SG Meditech Pte Ltd is a Singapore-based medical device company that is commercializing CANULEX, a novel device that collects cord blood more efficiently and safely compared to conventional methods. The company is currently incubated under The Biofactory, an ISO 13485-certified biomedical incubator. The practice of delayed cord clamping significantly reduces the number of viable cord blood units that can be banked for future transplant use. CANULEX helps cord blood banks to minimize the impact of delayed cord clamping by maximizing the volume of cord blood that can be collected at each opportunity. CANULEX has been engineered to optimize each cord blood collection opportunity. Its features include: - Device can be clamped on the umbilical cord enabling hands-free, continuous in-to-ex utero collection and an extended collection window - Larger needle diameter - Retractable needle - Minimal interruption to obstetric procedures